Portal de Periódicos da CAPES

Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination

2014; Elsevier BV; Volume: 32; Issue: 30 Linguagem: Inglês

10.1016/j.vaccine.2014.04.050

1873-2518

Nicola Decaro, Giuseppe Crescenzo, Costantina Desario, Alessandra Cavalli, Michele Losurdo, Maria Loredana Colaianni, G. Ventrella, Stefania Rizzi, Stefano Aulicino, Maria Stella Lucente, Canio Buonavoglia,

Viral gastroenteritis research and epidemiology

Canine parvovirus (CPV) modified live virus vaccines are able to infect vaccinated dogs replicating in the bloodstream and enteric mucosa. However, the exact duration and extent of CPV vaccine-induced viremia and fecal shedding are not known. With the aim to fill this gap, 26 dogs were administered two commercial vaccines containing a CPV-2 or CPV-2b strain and monitored for 28 days after vaccination. By using real-time PCR, vaccine-induced viremia and shedding were found to be long lasting for both vaccinal strains. Vaccinal CPV-2b shedding was detected for a shorter period than CPV-2 (12 against 19 mean days) but with greater viral loads, whereas viremia occurred for a longer period (22 against 19 mean days) and with higher titers for CPV-2b. Seroconversion appeared as early as 7 and 14 days post-vaccination for CPV-2b and CPV-2 vaccines, respectively. With no vaccine there was any diagnostic interference using in-clinic or hemagglutination test, since positive results were obtained only by fecal real-time PCR testing. The present study adds new insights into the CPV vaccine persistence in the organism and possible interference with diagnostic tests.